Alnylam Pharmaceuticals (ALNY) Construction in Progress (2012 - 2018)

Alnylam Pharmaceuticals (ALNY) has 7 years of Construction in Progress data on file, last reported at $261.0 million in Q4 2018.

• For the quarter ending Q4 2018, Construction in Progress rose 95.27% year-over-year to $261.0 million; the trailing twelve-month figure through Dec 2018 stood at $261.0 million (up 95.27% YoY), and the FY2018 full-year result was $261.0 million, up 95.27% from the prior year.
• Construction in Progress for Q4 2018 stood at $261.0 million, up from $133.6 million in the prior quarter.
• Across five years, Construction in Progress topped out at $261.0 million in Q4 2018 and bottomed at $1.3 million in Q4 2015.
• The 5-year median for Construction in Progress is $68.2 million (2016), against an average of $93.2 million.
• The widest annual swing landed in 2014, when Construction in Progress jumped 6978.57%; it then slumped 35.17% in 2015.
• A 5-year view of Construction in Progress shows it stood at $2.0 million in 2014, then plunged by 35.17% to $1.3 million in 2015, then surged by 5205.99% to $68.2 million in 2016, then soared by 96.01% to $133.6 million in 2017, then jumped by 95.27% to $261.0 million in 2018.
• The last three Construction in Progress figures came in at $261.0 million (Q4 2018), $133.6 million (Q4 2017), and $68.2 million (Q4 2016), per Business Quant data.

Peer Comparison